The OLYSENSE Platform Aims to Strengthen Clinical Decision-Making by Leveraging Cloud-based Connectivity and AI Computing...
Award recognizes HemoSonics’ impactful marketing and ability to communicate the value of its Quantra Hemostasis System, which provides comprehensive blood analysis detailing hemostasis in the operating room in less than 15 minutes ...
A new technology marks a turning point in the treatment of early-stage breast cancer ...
Retrospective study from Alaska Hearing & Tinnitus Center shows 91.5% responder rate and significant improvement in Tinnitus Handicap Inventory scores after 12 weeks of treatment....
This milestone partnership supports the mission of both organizations to improve clinical trials through advanced medical technology. ...
New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent ...
New VIO® 3n and VIO® seal systems offer customized solutions to enhance surgical efficiency, precision, and safety across a variety of clinical applications. ...
Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic surgery in the U.S. presented as a late-breaker at the American Urologic Association annual meeting...
First AI-powered tool for real-time prostate volume and PSA density measurement aims to streamline urologic diagnostics in primary care settings. ...
Enhanced the supply capabilities of Neuraceq® to increase patient access to beta-amyloid PET imaging ...
